Bullock NS - Search Results

1

BCNU-sequestration by metallothioneins may contribute to resistance in a medulloblastoma cell line.

Bacolod MD, Fehdrau R, Johnson SP, Bullock NS, Bigner DD, Colvin M, Friedman HS. Bacolod MD, et al. Among authors: bullock ns. Cancer Chemother Pharmacol. 2009 Mar;63(4):753-8. doi: 10.1007/s00280-008-0792-9. Epub 2008 Jul 17. Cancer Chemother Pharmacol. 2009. PMID: 18633619 Free PMC article.

2

The gene expression profiles of medulloblastoma cell lines resistant to preactivated cyclophosphamide.

Bacolod MD, Lin SM, Johnson SP, Bullock NS, Colvin M, Bigner DD, Friedman HS. Bacolod MD, et al. Among authors: bullock ns. Curr Cancer Drug Targets. 2008 May;8(3):172-9. doi: 10.2174/156800908784293631. Curr Cancer Drug Targets. 2008. PMID: 18473730 Free PMC article.

3

Mechanisms of resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea in human medulloblastoma and rhabdomyosarcoma.

Bacolod MD, Johnson SP, Ali-Osman F, Modrich P, Bullock NS, Colvin OM, Bigner DD, Friedman HS. Bacolod MD, et al. Among authors: bullock ns. Mol Cancer Ther. 2002 Jul;1(9):727-36. Mol Cancer Ther. 2002. PMID: 12479369

4

Brain tumor cell lines resistant to O6-benzylguanine/1,3-bis(2-chloroethyl)-1-nitrosourea chemotherapy have O6-alkylguanine-DNA alkyltransferase mutations.

Bacolod MD, Johnson SP, Pegg AE, Dolan ME, Moschel RC, Bullock NS, Fang Q, Colvin OM, Modrich P, Bigner DD, Friedman HS. Bacolod MD, et al. Among authors: bullock ns. Mol Cancer Ther. 2004 Sep;3(9):1127-35. Mol Cancer Ther. 2004. PMID: 15367707

5

Cyclophosphamide resistance in medulloblastoma.

Friedman HS, Colvin OM, Kaufmann SH, Ludeman SM, Bullock N, Bigner DD, Griffith OW. Friedman HS, et al. Cancer Res. 1992 Oct 1;52(19):5373-8. Cancer Res. 1992. PMID: 1356617

6

Repair analysis of 4-hydroperoxycyclophosphamide-induced DNA interstrand crosslinking in the c-myc gene in 4-hydroperoxycyclophosphamide-sensitive and -resistant medulloblastoma cell lines.

Dong Q, Bullock N, Ali-Osman F, Colvin OM, Bigner DD, Friedman HS. Dong Q, et al. Cancer Chemother Pharmacol. 1996;37(3):242-46. doi: 10.1007/BF00688323. Cancer Chemother Pharmacol. 1996. PMID: 8529284

7

Multiple DNA repair mechanisms and alkylator resistance in the human medulloblastoma cell line D-283 Med (4-HCR).

Dong Q, Johnson SP, Colvin OM, Bullock N, Kilborn C, Runyon G, Sullivan DM, Easton J, Bigner DD, Nahta R, Marks J, Modrich P, Friedman HS. Dong Q, et al. Cancer Chemother Pharmacol. 1999;43(1):73-9. doi: 10.1007/s002800050865. Cancer Chemother Pharmacol. 1999. PMID: 9923544

8

Modulation of cyclophosphamide activity by O6-alkylguanine-DNA alkyltransferase.

Friedman HS, Pegg AE, Johnson SP, Loktionova NA, Dolan ME, Modrich P, Moschel RC, Struck R, Brent TP, Ludeman S, Bullock N, Kilborn C, Keir S, Dong Q, Bigner DD, Colvin OM. Friedman HS, et al. Cancer Chemother Pharmacol. 1999;43(1):80-5. doi: 10.1007/s002800050866. Cancer Chemother Pharmacol. 1999. PMID: 9923545

9

Bifunctional DNA alkylator 1,3-bis(2-chloroethyl)-1-nitrosourea activates the ATR-Chk1 pathway independently of the mismatch repair pathway.

Cui B, Johnson SP, Bullock N, Ali-Osman F, Bigner DD, Friedman HS. Cui B, et al. Mol Pharmacol. 2009 Jun;75(6):1356-63. doi: 10.1124/mol.108.053124. Epub 2009 Mar 4. Mol Pharmacol. 2009. PMID: 19261750 Free PMC article.

10

Decoupling of DNA damage response signaling from DNA damages underlies temozolomide resistance in glioblastoma cells.

Cui B, Johnson SP, Bullock N, Ali-Osman F, Bigner DD, Friedman HS. Cui B, et al. J Biomed Res. 2010 Nov;24(6):424-35. doi: 10.1016/S1674-8301(10)60057-7. J Biomed Res. 2010. PMID: 23554659 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters